EverSource Wealth Advisors’s Belite Bio BLTE Stock Holding History

EverSource Wealth Advisors’s Portfolio BLTE Stock Details BLTE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$12.2K	Buy	72 +66	+1,100%	+$10.7K	﹤0.01%	2782
2026 Q2	$924	Sell	6 -1,602	-100%	-$246K	﹤0.01%	3991
2026 Q1	$256K	Buy	1,608 +10	+0.6%	+$1.68K	0.01%	922
2025 Q4	$256K	Sell	1,598 -108	-6%	-$12.8K	0.01%	835
2025 Q3	$126K	Sell	1,706 -844	-33%	-$55.4K	0.01%	1155
2025 Q2	$147K	Buy	+2,550	New	+$156K	0.01%	1009

Other funds holding BLTE

Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return

High Net Worth Advisory Group Naples, Florida $476M AUM 15.5% 1-Year Est. Return

Dymon Asia Capital (Singapore) Singapore $2.21B AUM 109.09% 1-Year Est. Return

SmartHarvest Portfolios Poulsbo, Washington $258M AUM 39.79% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Vise Technologies New York $12B AUM 18.78% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

EverSource Wealth Advisors's BLTE Position: Q3 2026 in Review

EverSource Wealth Advisors increased its Belite Bio (BLTE) stake by 1,100% in Q3 2026, buying an estimated $10.7K and bringing the position to 72 shares worth $12.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2782.

EverSource Wealth Advisors first reported a position in BLTE in Q2 2025 and has held it in 6 quarters since. The position peaked at $256K in Q1 2026. 18 funds tracked by Wall St. Rank hold BLTE as of Q3 2026.

EverSource Wealth Advisors held 72 shares of Belite Bio worth $12.2K as of Q3 2026.
EverSource Wealth Advisors bought 66 Belite Bio shares in Q3 2026, an estimated $10.7K.
Belite Bio made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q3 2026, its #2782 holding.
EverSource Wealth Advisors first reported a position in Belite Bio in Q2 2025 and has held it in 6 quarters since.
EverSource Wealth Advisors's Belite Bio position peaked at $256K in Q1 2026.
18 funds tracked by Wall St. Rank held Belite Bio as of Q3 2026.

Based on EverSource Wealth Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.